Apparently, there was a big murder trial down South that culminated this week, but we have to admit that since it wasn't an overtly political case, we just didn't pay much attention to it. Instead, as always, we had our nose to the grindstone of sifting through the week's political news so that you don't have to. In other words: Welcome to another installment of Friday Talking Points!

We're going to start this week with some good news. Not great news, mind you, but pretty good nonetheless. A spate of actual bipartisanship broke out in the Senate this week and with amazing speed (for Congress in general and for the Senate in particular) they came up with proposed legislation that might actually have a chance of passing. Well, passing the Senate at least, since nobody has any clue of what the GOP House will do these days.

Read Complete Article »

Today, I'm going to do something I rarely do in this column: praise Marco Rubio. Because Rubio has been the driving force behind trying to change a system that virtually everyone hates, but that which will also probably continue for quite some time to come. And time is the heart of the issue, because I am speaking of the biannual change to and from daylight saving time.

Read Complete Article »

Pharmaceutical giant Eli Lilly announced today that they would be slashing their prices for insulin by 70 percent. Think about that for a moment -- a corporation was pricing a product so high that it can cut the price by 70 percent and still make money off of it. That should be seen as nothing short of obscene to the average person. But what is interesting about this announcement is that it seems a combination of public shame and some competition in the marketplace has brought about this change. And that's worth celebrating a little bit, even if the case isn't exactly cut-and-dried.

Read Complete Article »